Citadel Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $152K | Sell |
|
|||||
|
2018
Q2 | $482K | Buy |
|
|||||
|
2018
Q1 | $162K | Sell |
|
|||||
|
2017
Q4 | $1.12M | Buy |
|
|||||
|
2017
Q3 | $1.07M | Buy |
|
|||||
|
2017
Q2 | $782K | Sell |
|
|||||
|
2017
Q1 | $912K | Buy |
|
|||||
|
2016
Q4 | $277K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.08M | Buy |
|
|||||
|
2016
Q1 | $434K | Buy |
|
|||||
|
2015
Q4 | $0 | Sell |
|
|||||
|
2015
Q3 | $146K | Buy |
|
|||||
|
2015
Q2 | $262K | Sell |
|
|||||
|
2015
Q1 | $342K | Sell |
|
|||||
|
2014
Q4 | $1.63M | Sell |
|
|||||
|
2014
Q3 | $3.13M | Buy |
|
|||||
|
2014
Q2 | $289K | Sell |
|
|||||
|
2014
Q1 | $3.51M | Buy |
|
|||||
|
2013
Q4 | $2.19M | Buy |
|
|||||
|
2013
Q3 | $423K | Sell |
|
|||||
|
2013
Q2 | $472K | Buy |
|